[PDF][PDF] Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor
FoxP3 is a key transcription factor for the development and function of natural CD4 + regulatory
T cells (Treg cells). Here we show that human FoxP3 + CD4 + T cells were composed of …
T cells (Treg cells). Here we show that human FoxP3 + CD4 + T cells were composed of …
IgA dominates the early neutralizing antibody response to SARS-CoV-2
…, K Dorgham, P Charneau, Z Amoura… - Science translational …, 2021 - science.org
Humoral immune responses are typically characterized by primary IgM antibody responses
followed by secondary antibody responses associated with immune memory and composed …
followed by secondary antibody responses associated with immune memory and composed …
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
S Rust, M Rosier, H Funke, J Real, Z Amoura… - Nature …, 1999 - nature.com
Tangier disease (TD) was first discovered nearly 40 years ago in two siblings living on Tangier
Island 1. This autosomal co-dominant condition is characterized in the homozygous state …
Island 1. This autosomal co-dominant condition is characterized in the homozygous state …
[HTML][HTML] Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) …
GK Bertsias, M Tektonidou, Z Amoura… - Annals of the …, 2012 - ard.bmj.com
Objectives To develop recommendations for the management of adult and paediatric lupus
nephritis (LN). Methods The available evidence was systematically reviewed using the …
nephritis (LN). Methods The available evidence was systematically reviewed using the …
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria
…, F Manneville, MC Amigo, Z Amoura… - Arthritis & …, 2023 - Wiley Online Library
Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …
specificity for use in observational studies and trials, jointly supported by the American …
EULAR recommendations for the management of antiphospholipid syndrome in adults
…, L Andreoli, M Limper, Z Amoura… - Annals of the …, 2019 - ard.bmj.com
The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E …
…, S Besnard, J Donadieu, Z Amoura - Blood, The Journal …, 2013 - ashpublications.org
Histiocytoses are rare disorders of unknown origin with highly heterogeneous prognosis.
BRAF V600E gain-of-function mutations have been observed in 57% of cases of Langerhans …
BRAF V600E gain-of-function mutations have been observed in 57% of cases of Langerhans …
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
…, A Fernández-Nebro, M Haro, Z Amoura… - Annals of the …, 2015 - ard.bmj.com
Objectives To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid
syndrome (APS) during a 10-year-follow-up period and to compare the frequency of …
syndrome (APS) during a 10-year-follow-up period and to compare the frequency of …
Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal …
Z Amoura, S Koutouzov, H Chabre… - … : Official Journal of …, 2000 - Wiley Online Library
… Amoura and Koutouzov contributed equally to this work. Address reprint requests to Zahir
Amoura, MD, Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrie`re, 47-83 Boule…
Amoura, MD, Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrie`re, 47-83 Boule…
Global natural regulatory T cell depletion in active systemic lupus erythematosus
The immune defect that could account for the multisystemic involvement that characterizes
systemic lupus erythematosus (SLE) remains unknown. We hypothesized that iterative …
systemic lupus erythematosus (SLE) remains unknown. We hypothesized that iterative …